Burden of hospitalization of patients with Candida and Aspergillus infections in Australia.
Int J Infect Dis
; 8(2): 111-20, 2004 Mar.
Article
em En
| MEDLINE
| ID: mdl-14732329
ABSTRACT
OBJECTIVES:
This study examined the burden of hospitalization of patients with Aspergillus and Candida infections in Australia from 1995 to 1999.METHODS:
Data were extracted from the National Hospital Morbidity Database. A hospitalization with an aspergillosis diagnosis was defined as any discharge with a diagnosis of aspergillosis. A hospitalization with a candidiasis diagnosis was defined as any discharge with a diagnosis of disseminated, invasive, or non-invasive candidiasis. Outcome measures included number of hospitalizations, length of stay (LOS), cost (AUS$), and mortality.RESULTS:
4583 hospitalizations with an aspergillosis diagnosis and 57,758 hospitalizations with a candidiasis diagnosis were identified. These hospitalizations were associated with a total of 813,398 hospital days, AUS$563 million in cost, and 4967 in-hospital deaths during the study period. The mean LOS for a hospitalization with an aspergillosis diagnosis was 12 days, cost AUS$9,334, and was associated with 8% mortality. For disseminated, invasive, and non-invasive candidiasis, the respective mean LOS were 31, 17, and 12 days; costs were AUS$33,274, AUS$12,954, and AUS$7,694; and mortality was 26%, 9%, and 8%.CONCLUSIONS:
Hospitalizations with diagnoses for fungal infections were associated with lengthy hospital stays, high costs, and high mortality.
Buscar no Google
Bases de dados:
MEDLINE
Assunto principal:
Aspergilose
/
Candidíase
/
Hospitalização
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
País/Região como assunto:
Oceania
Idioma:
En
Revista:
Int J Infect Dis
Assunto da revista:
DOENCAS TRANSMISSIVEIS
Ano de publicação:
2004
Tipo de documento:
Article
País de afiliação:
Austrália